from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2198c/mmpS3

LFCtreatmentdescriptionclass of inhibitor

-0.552

Amikacinug/mL Amikacintranslation

-0.930

Cap5-10ug/mL Capreomycintranslation

-1.579

Rox10-50 ug/mL Roxithromycintranslation

-0.185

SM2-5 ug/mL Streptomycintranslation

0.145

Tet5-10 ug/mL Tetracyclinetranslation

0.783

Rif0.2-5ug/mL Rifampicintranscription

0.244

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.296

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.515

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.037

CPZ10-50 ug/mL Chlorpromazinerespiration

0.408

Clofazimine10-13 ug/mL Clofaziminerespiration

0.530

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.351

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.190

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.316

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.510

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.167

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.084

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.138

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.369

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.473

KCN5-20 ug/mL Potassium cyaniderespiration

0.698

NaN30.2-2 mM Sodium aziderespiration

-0.865

Nigericin50 uM Nigericinrespiration

-0.288

TRC10-150 ug/mL Triclosanrespiration

-1.380

TRZ10-25 ug/mL Thioridazinerespiration

-2.094

Valinomycin0.5-10 uM Valinomycinrespiration

1.085

ZnSO42 mM ZnSO4respiration

-0.584

menadione6-10 ug/mL Menadionerespiration

-0.723

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.266

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.303

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.069

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.387

NRP_1Non-replicating persistence stage 1dosRassociated

0.548

Amp0.2mg/mL AmpicillincellWall

0.534

Cephalexin20-100 ug/mL CephalexincellWall

-0.051

Cerulenin0.32-5 ug/mL CerulenincellWall

0.363

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.726

EMB10-20 ug/mL EthambutolcellWall

0.191

Eta12-40 ug/mL EthionamidecellWall

0.077

INH0.2-0.4 ug/mL IsoniazidcellWall

0.145

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.876

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.854

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.271

BZA0.12 mg/mL BenzamidearomaticAmides

-0.094

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.051

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.273

H2O24 mM hydrogen peroxideDNAdamaging

-0.824

Levo10 ug/mL LevofloxacinDNAdamaging

0.276

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.490

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.276

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.285

UVUV-irradiationDNAdamaging

0.549

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.699

Antimycin12.5-50 ug/mL Antimycin A?

0.924

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.559

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.016

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.033

PA8240.2-2 ug/mL PA-824?

-0.096

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.367

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.315

Verapamil50 uM Verapamil?

-0.029

mercaptoethanol2 mM 2-Mercaptoethanol?

0.816

methoxatin10-20 ug/mL Methoxatin?